WORK Medical Technology Group LTD (WOK) Stock

About WORK Medical Technology Group LTD

WORK Medical Technology Group LTD is led by CEO Shuang Wu, publicly traded since 2024.

WORK Medical Technology Group LTD (WOK) stock trades at $1.11 with a market capitalization of $2.68M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.01, reflecting a net loss over the last twelve months, price-to-book of 0.20, price-to-sales of 0.33. Over the past 52 weeks the stock has ranged between $1.09 and $105000.00, and currently trades 100.0% below its 52-week high.

On profitability, WORK Medical Technology Group LTD generates a return on equity (ROE) of -18.55% (negative, reflecting a net loss), return on capital employed of -13.74%, an operating margin of -20.00%, a net profit margin of -41.95%.

WORK Medical Technology Group LTD by the numbers, 2020–2025

Between 2020 and 2025 WORK Medical Technology Group LTD reported revenue of $53.0M rising to $10.0M, a change of -81.1% across 6 years. Compounded, revenue has grown -28.4% a year over five years, -20.6% over three, -16.7% over the last twelve months. Net profit fell to $-1.0M.

Operating margin went from 11.4% in 2020 to -25.3% in 2025, a fall of 36.7 percentage points. The most recent net margin is -41.95%. On a trailing twelve-month basis to Mar '26, revenue is $21.0M and net profit $-8.0M.

Borrowings rose from $4.0M to $6.0M, cash from operations was $6.0M in the latest year, positive in 3 of the last 6.

Return on equity has averaged 8.3% over five years, and was -5.6% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

WORK Medical Technology Group LTD (WOK) — frequently asked questions